Investigating the Direct Superior Approach for Total Hip Arthroplasty as an Effective Alternative to Traditional Posterior Approach
1 other identifier
interventional
48
1 country
1
Brief Summary
Hip replacement surgery is an effective option for treating pain and functional impairment in chronic hip conditions. Various surgical approaches have been developed to expose the hip joint for the procedure, each with advantages and disadvantages. The posterior approach (PA) to total hip replacement is a commonly used exposure method. This approach involves a large incision and requires multiple cuts through muscle and other soft tissues to expose the hip joint. Despite excellent outcomes, the PA is known to have an increased rate of dislocation compared to other exposures. The direct superior (DS) approach has been developed to improve the PA by decreasing the amount of soft tissue injury at the time of surgery and improving postoperative stability. The DS approach involves a much shorter incision and reduces the need to damage as much soft tissues surrounding the hip joint during exposure. Specialized equipment developed for this technique allows the surgeon to place the hip replacement components. The proposed research study is designed to address a deficit in knowledge regarding outcomes on patients who have had a DS approach for total hip arthroplasty. This study will provide much needed insight into the advantages and disadvantages of the DS approach as compared to PA for total hip arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2017
CompletedFirst Posted
Study publicly available on registry
July 24, 2017
CompletedStudy Start
First participant enrolled
July 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 21, 2024
August 1, 2024
7 years
June 22, 2017
August 19, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
EQ-5D patient reported outcome measure
Health status measure
2 years
Oxford-12 patient reported outcome measure
Functional outcome measure
2 years
Secondary Outcomes (1)
Length of stay
0 - 30 days
Study Arms (2)
Direct Superior Approach
EXPERIMENTALThe intervention being tested is the surgical approach.
Posterior Approach
ACTIVE COMPARATORInterventions
Total hip arthroplasty using direct superior approach
Total Hip Arthroplasty using direct superior or posterior approach
Eligibility Criteria
You may qualify if:
- Symptomatic osteoarthritis of the hip indicating surgical intervention
- Uncemented femoral stem and acetabular cup indicated
- Patients between the ages of 18 and 80, inclusive.
- Ability to give informed consent
You may not qualify if:
- Patients less than 18 years of age, or 81 years of age and older
- Active or prior infection of the affected hip
- Morbid obesity (BMI \> 45)
- Medical condition precluding major surgery
- Severe osteoporosis or osteopenia
- Neuromuscular impairment
- Patients with known or tested-positive allergy to metals
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Capital District Health Authority
Halifax, Nova Scotia, B3H 3A7, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2017
First Posted
July 24, 2017
Study Start
July 10, 2018
Primary Completion
July 10, 2025
Study Completion
December 1, 2025
Last Updated
August 21, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share